436 related articles for article (PubMed ID: 28682886)
21. Efficacy of multidisciplinary interventions in preventing metabolic syndrome and improving body composition in prostate cancer patients treated with androgen deprivation therapy: A systematic review and meta-analysis.
Yang U; Harikrishna A; Preda V; Chen J
Clin Nutr ESPEN; 2023 Dec; 58():27-49. PubMed ID: 38057016
[TBL] [Abstract][Full Text] [Related]
22. Football training improves lean body mass in men with prostate cancer undergoing androgen deprivation therapy.
Uth J; Hornstrup T; Schmidt JF; Christensen JF; Frandsen C; Christensen KB; Helge EW; Brasso K; Rørth M; Midtgaard J; Krustrup P
Scand J Med Sci Sports; 2014 Aug; 24 Suppl 1():105-12. PubMed ID: 24944134
[TBL] [Abstract][Full Text] [Related]
23. The use of exercise interventions to overcome adverse effects of androgen deprivation therapy.
Østergren PB; Kistorp C; Bennedbæk FN; Faber J; Sønksen J; Fode M
Nat Rev Urol; 2016 Jun; 13(6):353-64. PubMed ID: 27112391
[TBL] [Abstract][Full Text] [Related]
24. The effects of exercise on body composition of prostate cancer patients receiving androgen deprivation therapy: An update systematic review and meta-analysis.
Shao W; Zhang H; Qi H; Zhang Y
PLoS One; 2022; 17(2):e0263918. PubMed ID: 35167609
[TBL] [Abstract][Full Text] [Related]
25. Physical exercise for bone health in men with prostate cancer receiving androgen deprivation therapy: a systematic review.
Bressi B; Cagliari M; Contesini M; Mazzini E; Bergamaschi FAM; Moscato A; Bassi MC; Costi S
Support Care Cancer; 2021 Apr; 29(4):1811-1824. PubMed ID: 33119791
[TBL] [Abstract][Full Text] [Related]
26. Onset of androgen deprivation therapy leads to rapid deterioration of body composition, physical performance, cardiometabolic health and quality-of-life in prostate cancer patients.
Overkamp M; Houben LHP; van der Meer S; van Roermund JGH; Bos R; Kokshoorn APJ; Larsen MS; van Loon LJC; Beelen M; Beijer S
Scand J Urol; 2023; 57(1-6):60-66. PubMed ID: 36703515
[TBL] [Abstract][Full Text] [Related]
27. Exercise improves quality of life in androgen deprivation therapy-treated prostate cancer: systematic review of randomised controlled trials.
Teleni L; Chan RJ; Chan A; Isenring EA; Vela I; Inder WJ; McCarthy AL
Endocr Relat Cancer; 2016 Feb; 23(2):101-12. PubMed ID: 26584972
[TBL] [Abstract][Full Text] [Related]
28. Exercise Mode Specificity for Preserving Spine and Hip Bone Mineral Density in Prostate Cancer Patients.
Newton RU; Galvão DA; Spry N; Joseph D; Chambers SK; Gardiner RA; Wall BA; Bolam KA; Taaffe DR
Med Sci Sports Exerc; 2019 Apr; 51(4):607-614. PubMed ID: 30395051
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of a multi-component exercise programme and nutritional supplementation on musculoskeletal health in men treated with androgen deprivation therapy for prostate cancer (IMPACT): study protocol of a randomised controlled trial.
Owen PJ; Daly RM; Livingston PM; Mundell NL; Dalla Via J; Millar JL; Fraser SF
Trials; 2017 Oct; 18(1):451. PubMed ID: 28974267
[TBL] [Abstract][Full Text] [Related]
30. Time on androgen deprivation therapy and adaptations to exercise: secondary analysis from a 12-month randomized controlled trial in men with prostate cancer.
Taaffe DR; Buffart LM; Newton RU; Spry N; Denham J; Joseph D; Lamb D; Chambers SK; Galvão DA
BJU Int; 2018 Feb; 121(2):194-202. PubMed ID: 28872752
[TBL] [Abstract][Full Text] [Related]
31. Quantifying observational evidence for risk of fatal and nonfatal cardiovascular disease following androgen deprivation therapy for prostate cancer: a meta-analysis.
Bosco C; Bosnyak Z; Malmberg A; Adolfsson J; Keating NL; Van Hemelrijck M
Eur Urol; 2015 Sep; 68(3):386-96. PubMed ID: 25484142
[TBL] [Abstract][Full Text] [Related]
32. Does Androgen Deprivation for Prostate Cancer Affect Normal Adaptation to Resistance Exercise?
Nilsen TS; Johansen SH; Thorsen L; Fairman CM; Wisløff T; Raastad T
Int J Environ Res Public Health; 2022 Mar; 19(7):. PubMed ID: 35409505
[TBL] [Abstract][Full Text] [Related]
33. Feasibility and Safety of Physical Exercise to Preserve Bone Health in Men With Prostate Cancer Receiving Androgen Deprivation Therapy: A Systematic Review.
Cagliari M; Bressi B; Bassi MC; Fugazzaro S; Prati G; Iotti C; Costi S
Phys Ther; 2022 Mar; 102(3):. PubMed ID: 34972863
[TBL] [Abstract][Full Text] [Related]
34. Quantifying observational evidence for risk of dementia following androgen deprivation therapy for prostate cancer: an updated systematic review and meta-analysis.
Cui H; Wang Y; Li F; He G; Jiang Z; Gang X; Wang G
Prostate Cancer Prostatic Dis; 2021 Mar; 24(1):15-23. PubMed ID: 32814845
[TBL] [Abstract][Full Text] [Related]
35. Depressive symptoms are found to be potential adverse effects of androgen deprivation therapy in older prostate cancer patients: A 15-month prospective, observational study.
Zhang Z; Yang L; Xie D; Shi H; Li G; Yu D
Psychooncology; 2017 Dec; 26(12):2238-2244. PubMed ID: 28474429
[TBL] [Abstract][Full Text] [Related]
36. Effects of Different Exercise Modalities on Fatigue in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: A Year-long Randomised Controlled Trial.
Taaffe DR; Newton RU; Spry N; Joseph D; Chambers SK; Gardiner RA; Wall BA; Cormie P; Bolam KA; Galvão DA
Eur Urol; 2017 Aug; 72(2):293-299. PubMed ID: 28249801
[TBL] [Abstract][Full Text] [Related]
37. Football training in men with prostate cancer undergoing androgen deprivation therapy: activity profile and short-term skeletal and postural balance adaptations.
Uth J; Hornstrup T; Christensen JF; Christensen KB; Jørgensen NR; Helge EW; Schmidt JF; Brasso K; Helge JW; Jakobsen MD; Andersen LL; Rørth M; Midtgaard J; Krustrup P
Eur J Appl Physiol; 2016 Mar; 116(3):471-80. PubMed ID: 26620651
[TBL] [Abstract][Full Text] [Related]
38. A randomized controlled trial on the effectiveness of strength training on clinical and muscle cellular outcomes in patients with prostate cancer during androgen deprivation therapy: rationale and design.
Thorsen L; Nilsen TS; Raastad T; Courneya KS; Skovlund E; Fosså SD
BMC Cancer; 2012 Mar; 12():123. PubMed ID: 22458865
[TBL] [Abstract][Full Text] [Related]
39. Androgen Deprivation Therapy for Prostate Cancer and the Risk of Venous Thromboembolism.
Klil-Drori AJ; Yin H; Tagalakis V; Aprikian A; Azoulay L
Eur Urol; 2016 Jul; 70(1):56-61. PubMed ID: 26138040
[TBL] [Abstract][Full Text] [Related]
40. Lifestyle changes for improving disease-specific quality of life in sedentary men on long-term androgen-deprivation therapy for advanced prostate cancer: a randomised controlled trial.
Bourke L; Gilbert S; Hooper R; Steed LA; Joshi M; Catto JW; Saxton JM; Rosario DJ
Eur Urol; 2014 May; 65(5):865-72. PubMed ID: 24119318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
